Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost?

(MedPage Today) -- On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks -- heart attack, stroke, and death -- for obese or overweight adults with a history of cardiovascular disease, making it the first...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news